Similar Articles |
|
The Motley Fool February 15, 2007 Billy Fisher |
Taking FoxHollow's Pulse The medical-device maker gets a checkup from the market. Results were mixed, although the stock was trading down 4%. |
The Motley Fool May 4, 2007 Billy Fisher |
In Search of New Prey at FoxHollow The medical device maker reported a 6% increase in revenues on a year-over-year basis for its first-quarter. Investors, take note. |
The Motley Fool July 5, 2006 Glenn Brandys |
FoxHollow's SilverHawk Won't Soar Cost, time, and competition are holding back the med-tech's device for treating artery disease. Investors, take note. |
BusinessWeek June 20, 2005 Spencer E. Ante |
Powering Through Clogged Arteries FoxHollow's SilverHawk is a promising alternative to stents and bypass surgery. |
The Motley Fool May 5, 2006 Stephen D. Simpson |
FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock. |
The Motley Fool September 29, 2006 Brian Lawler |
Merck Likes FoxHollow The pharmaceutical giant signs another collaborative research agreement with the small-cap company. Investors, take note. |
The Motley Fool February 27, 2006 Stephen D. Simpson |
A Foxy Idea? Medical device maker Foxhollow is in an attractive niche, but management turnover is a reason for investors to worry. |
The Motley Fool December 29, 2006 Matthew Crews |
FoxHollow: Scale Is Critical Can this medical-device maker be a long-term success, or is it just a one-hit wonder? Investors, take note. |
The Motley Fool August 4, 2006 Stephen D. Simpson |
SilverHawk Flying Just Fine, Thanks With med-tech company FoxHollow Technologies, there is growth and risk in equal measure. Investors, take note. |
The Motley Fool May 2, 2007 |
Product Revenue Falls at FoxHollow Technologies: Fool by Numbers The medical device maker released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
CFO May 1, 2007 Joseph McCafferty |
The Long View Corporate managers have long complained about the pressure to focus on the short term, but now, for the first time, critics and business groups are racing to their defense. The cure for the myopia? Stop giving quarterly earnings guidance. |
The Motley Fool November 9, 2006 |
FoxHollow Technologies: Fool by Numbers The med-tech company released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |